Abstract Symposia Wednesday

Wednesday, July 3, 13.00-14.15

AS-25: Contact activation 2.0

  • Contact activation 2.0
    Thomas Renné

AS-26: Assays for haemostatic drugs

  • Assays for haemostatic drugs
    Steve Kitchen 

AS-27: Platelet response to injury

  • Re-thinking the platelet response to injury
    Lawrence Brass

AS-28: Thrombocytopenia

  • Thrombocytopenia: bridging basic and clinical research
    Andreas Greinacher

AS-29: Genetics in coagulation

  • Anticoagulant pathways: genotype-phenotype relationships
    Elisabetta Castoldi

AS-30: Thrombus resolution and stroke

  • Angiophagy: a mechanism of microvascular recanalization after embolic occlusion
    Jaime Grutzendler

AS-31: Coagulation and complement

  • Coagulation and complement
    Marcel Levi

AS-32: Treatment of Von Willebrand disease

  • Treatment of Von Willebrand disease
    Frank Leebeek

AS-33: Major bleeding

  • Bleeding and thrombosis in patients with liver disease
    Ton Lisman

AS-34: Venous thrombosis and cancer

  • Treatment of venous thromboembolism in cancer patients
    Dominique Farge-Bancel

AS-35: Clot structure

  • Determinants of clot stability
    Alisa Wolberg